Table C.17Model 2 base case resuts: cost-effective strategy by age and sex

MenWomen
Age 20No testing was cost-effectiveNo testing was cost-effective
Age 40No testing was cost-effectiveNo testing was cost-effective
Age 55No testing was cost-effectiveNo testing was cost-effective
Age 65No testing was cost-effectiveNo testing was cost-effective
Age 70No testing was cost-effectiveNo testing was cost-effective
Age 75No testing was cost-effectiveNo testing was cost-effective
Age 80ACR was cost-effective at £11,000/QALY compared with no testingACR was cost-effective at £11,000/QALY compared with no testing
*

Cost-effectiveness threshold=£20,000 per QALY gained

From: Appendix C, Health economic model – Cost effectiveness of CKD case finding among people at high risk

Cover of Chronic Kidney Disease
Chronic Kidney Disease: National Clinical Guideline for Early Identification and Management in Adults in Primary and Secondary Care.
NICE Clinical Guidelines, No. 73.
National Collaborating Centre for Chronic Conditions (UK).
Copyright © 2008, Royal College of Physicians of London.

All rights reserved. No part of this publication may be reproduced in any form (including photocopying or storing it in any medium by electronic means and whether or not transiently or incidentally to some other use of this publication) without the written permission of the copyright owner. Applications for the copyright owner’s written permission to reproduce any part of this publication should be addressed to the publisher.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.